HIGHLIGHTS
- who: Jinpeng Zheng and collaborators from the State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing, China School of Pharmacy, Guangxi Medical University, Nanning, China have published the article: Lung-Targeted Delivery of Cepharanthine by an Erythrocyte- Anchoring Strategy for the Treatment of Acute Lung Injury, in the Journal: Pharmaceutics 2022, 1820 of 30/06/2022
- what: Collectively, the E-CPA-CNPs in this study showed great prospect in the treatment of various clinical diseases such as pulmonary hypertension and respiratory infectious diseases (including COVID-19).
- how . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.